ClinicalTrials.gov record
Recruiting Phase 3 Interventional

A Study of TLC590 for Postsurgical Pain Following Bunionectomy

ClinicalTrials.gov ID: NCT07222748

Public ClinicalTrials.gov record NCT07222748. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 17, 2026, 10:24 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 3, Randomized, Double-blind, Comparator- and Placebo-controlled Study to Evaluate the Safety and Efficacy of TLC590 for Postsurgical Pain Management Following Bunionectomy

Study identification

NCT ID
NCT07222748
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 3
Lead sponsor
TLC Biopharmaceuticals, Inc.
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Liposomal Bupivacaine Drug
  • Saline Placebo Drug
  • TLC590 Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 16, 2025
Primary completion
Mar 31, 2026
Completion
Apr 30, 2026
Last update posted
Dec 1, 2025

2025 – 2026

United States locations

U.S. sites
4
U.S. states
2
U.S. cities
4
Facility City State ZIP Site status
Clinical Pharmacology of Miami Miami Florida 33172 Not yet recruiting
First Surgical Hospital Bellaire Texas 77401 Recruiting
Memorial Hermann Village Houston Texas 77043 Recruiting
Endeavor Clinical Trials San Antonio Texas 78240 Not yet recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07222748, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Dec 1, 2025 · Synced May 17, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07222748 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →